Michael J. Farrell, Chairman and CEO of ResMed Inc. ($RMD), sold shares on the open market 12 times in the past year for a total of $21.5 million. His latest sale occurred on March 9, 2026. These ResMed insider sales rank 637th among 11,678 individual insiders by total value, surpassing the average of $8.6 million across 6.4 transactions. Farrell made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Not found | A | Phantom Stock Units | 421 | $0.00 | 18,245.0330 | 318,700,000 | 2.36% | 0.00% |
| March 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 4991 | $146.34 | 473,304.0000 | 190,814,000 | 1.07% | 0.00% |
| March 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 4991 | $0.00 | 39,930.0000 | 190,814,000 | 11.11% | 0.00% |
| March 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | S | ResMed Common Stock | 4991 | $251.03 | 468,313.0000 | 190,814,000 | 1.05% | 0.00% |
| Feb. 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 4991 | $0.00 | 44,921.0000 | 190,814,000 | 10.00% | 0.00% |
| Feb. 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | S | ResMed Common Stock | 4991 | $273.78 | 468,313.0000 | 190,814,000 | 1.05% | 0.00% |
| Feb. 9, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 4991 | $146.34 | 473,304.0000 | 190,814,000 | 1.07% | 0.00% |
| Jan. 7, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 4991 | $146.34 | 473,304.0000 | 190,814,000 | 1.07% | 0.00% |
| Jan. 7, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 4991 | $0.00 | 49,912.0000 | 190,814,000 | 9.09% | 0.00% |
| Jan. 7, 2026 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | S | ResMed Common Stock | 4991 | $248.46 | 468,313.0000 | 190,814,000 | 1.05% | 0.00% |
| Dec. 31, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Not found | A | Phantom Stock Units | 415 | $0.00 | 17,775.6820 | 318,700,000 | 2.39% | 0.00% |
| Dec. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 4991 | $0.00 | 54,903.0000 | 190,390,000 | 8.33% | 0.00% |
| Dec. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 4991 | $146.34 | 473,304.0000 | 190,390,000 | 1.07% | 0.00% |
| Dec. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | S | ResMed Common Stock | 4991 | $251.41 | 468,313.0000 | 190,390,000 | 1.05% | 0.00% |
| Nov. 24, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | A | ResMed Common Stock Options | 33288 | $250.52 | 33,288.0000 | 190,390,000 | 9999.99% | 0.02% |
| Nov. 20, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | A | ResMed Common Stock | 13551 | $0.00 | 475,610.0000 | 190,390,000 | 2.93% | 0.01% |
| Nov. 20, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | F | ResMed Common Stock | 7297 | $0.00 | 468,313.0000 | 190,390,000 | 1.53% | 0.00% |
| Nov. 11, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | F | ResMed Common Stock | 3459 | $250.10 | 464,265.0000 | 190,390,000 | 0.74% | 0.00% |
| Nov. 11, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | F | ResMed Common Stock | 2232 | $250.10 | 467,724.0000 | 190,390,000 | 0.47% | 0.00% |
| Nov. 11, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | F | ResMed Common Stock | 2206 | $250.10 | 462,059.0000 | 190,390,000 | 0.48% | 0.00% |
| Nov. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 983 | $0.00 | 7,028.0000 | 190,390,000 | 12.27% | 0.00% |
| Nov. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 983 | $101.64 | 470,939.0000 | 190,390,000 | 0.21% | 0.00% |
| Nov. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock | 7028 | $101.64 | 477,967.0000 | 190,390,000 | 1.49% | 0.00% |
| Nov. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | S | ResMed Common Stock | 8011 | $249.75 | 469,956.0000 | 190,390,000 | 1.68% | 0.00% |
| Nov. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chairman and CEO | M | ResMed Common Stock Options | 7028 | $0.00 | 0.0000 | 190,390,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $282.85 | 469,882.0000 | 190,390,000 | 1.68% | 0.00% |
| Oct. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 477,891.0000 | 190,390,000 | 1.70% | 0.00% |
| Oct. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 8,011.0000 | 190,390,000 | 49.99% | 0.00% |
| Sept. 30, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Not found | A | Phantom Stock Units | 382 | $0.00 | 17,318.9480 | 318,400,000 | 2.26% | 0.00% |
| Sept. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $278.14 | 469,882.0000 | 190,311,000 | 1.68% | 0.00% |
| Sept. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 16,020.0000 | 190,311,000 | 33.33% | 0.00% |
| Sept. 8, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 477,891.0000 | 190,311,000 | 1.70% | 0.00% |
| Aug. 15, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | A | ResMed Common Stock | 12289 | $0.00 | 469,882.0000 | 190,311,000 | 2.69% | 0.01% |
| Aug. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 24,029.0000 | 190,311,000 | 25.00% | 0.00% |
| Aug. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $279.48 | 457,593.0000 | 190,311,000 | 1.72% | 0.00% |
| Aug. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,602.0000 | 190,311,000 | 1.75% | 0.00% |
| July 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 463,512.0000 | 190,311,000 | 1.76% | 0.00% |
| July 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 32,038.0000 | 190,311,000 | 20.00% | 0.00% |
| July 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $256.72 | 455,503.0000 | 190,311,000 | 1.73% | 0.00% |
| June 30, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 466 | $0.00 | 16,894.0070 | 317,500,000 | 2.84% | 0.00% |
| June 9, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $251.21 | 457,593.0000 | 190,049,000 | 1.72% | 0.00% |
| June 9, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,602.0000 | 190,049,000 | 1.75% | 0.00% |
| June 9, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 40,047.0000 | 190,049,000 | 16.67% | 0.00% |
| May 29, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 810 | $0.00 | 16,427.5380 | 317,500,000 | 5.19% | 0.00% |
| May 29, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Restricted Stock Units | 1405 | $0.00 | 12,239.7260 | 317,500,000 | 12.97% | 0.00% |
| May 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,602.0000 | 190,049,000 | 1.75% | 0.00% |
| May 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 48,056.0000 | 190,049,000 | 14.29% | 0.00% |
| May 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $243.23 | 457,593.0000 | 190,049,000 | 1.72% | 0.00% |
| April 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,572.0000 | 190,049,000 | 1.75% | 0.00% |
| April 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 56,065.0000 | 190,049,000 | 12.50% | 0.00% |
| April 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $209.85 | 457,562.0000 | 190,049,000 | 1.72% | 0.00% |
| March 31, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 289 | $0.00 | 15,580.5000 | 317,500,000 | 1.89% | 0.00% |
| March 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,571.0000 | 190,049,000 | 1.75% | 0.00% |
| March 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 64,074.0000 | 190,049,000 | 11.11% | 0.00% |
| March 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $229.20 | 457,562.0000 | 190,049,000 | 1.72% | 0.00% |
| Feb. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 8009 | $236.77 | 457,562.0000 | 190,049,000 | 1.72% | 0.00% |
| Feb. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 8009 | $0.00 | 72,083.0000 | 190,049,000 | 10.00% | 0.00% |
| Feb. 7, 2025 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 8009 | $101.64 | 465,571.0000 | 190,049,000 | 1.75% | 0.00% |
| Dec. 31, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 307 | $0.00 | 15,259.0330 | 317,400,000 | 2.06% | 0.00% |
| Nov. 25, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | A | ResMed Common Stock Options | 33036 | $249.56 | 33,036.0000 | 189,662,000 | 9999.99% | 0.02% |
| Nov. 27, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 2000 | $249.67 | 457,562.0000 | 189,662,000 | 0.44% | 0.00% |
| Nov. 27, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | G | ResMed Common Stock | 2000 | $0.00 | 459,562.0000 | 189,662,000 | 0.44% | 0.00% |
| Nov. 27, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | G | ResMed Common Stock | 2000 | $0.00 | 457,562.0000 | 189,662,000 | 0.44% | 0.00% |
| Nov. 11, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | F | ResMed Common Stock | 3453 | $252.38 | 459,562.0000 | 189,662,000 | 0.75% | 0.00% |
| Nov. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 483,027.0000 | 189,662,000 | 3.14% | 0.01% |
| Nov. 11, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | F | ResMed Common Stock | 2227 | $252.38 | 463,015.0000 | 189,662,000 | 0.48% | 0.00% |
| Nov. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 0.0000 | 189,662,000 | 100.00% | 0.01% |
| Nov. 11, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | F | ResMed Common Stock | 3101 | $252.38 | 465,242.0000 | 189,662,000 | 0.66% | 0.00% |
| Nov. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $246.26 | 468,344.0000 | 189,662,000 | 3.04% | 0.01% |
| Oct. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $231.91 | 468,259.0000 | 189,662,000 | 3.04% | 0.01% |
| Oct. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 482,942.0000 | 189,662,000 | 3.14% | 0.01% |
| Oct. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 14,683.0000 | 189,662,000 | 50.00% | 0.01% |
| Sept. 30, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 302 | $0.00 | 14,918.5410 | 317,200,000 | 2.06% | 0.00% |
| Sept. 9, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $248.38 | 468,259.0000 | 189,565,000 | 3.04% | 0.01% |
| Sept. 9, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 482,942.0000 | 189,565,000 | 3.14% | 0.01% |
| Sept. 9, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 29,366.0000 | 189,565,000 | 33.33% | 0.01% |
| Aug. 15, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | A | ResMed Common Stock | 4098 | $0.00 | 468,259.0000 | 189,565,000 | 0.88% | 0.00% |
| Aug. 15, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | A | ResMed Common Stock | 19272 | $0.00 | 464,161.0000 | 189,565,000 | 4.33% | 0.01% |
| Aug. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 44,049.0000 | 189,565,000 | 25.00% | 0.01% |
| Aug. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $214.25 | 444,889.0000 | 189,565,000 | 3.19% | 0.01% |
| Aug. 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 459,572.0000 | 189,565,000 | 3.30% | 0.01% |
| July 8, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 58,732.0000 | 189,565,000 | 20.00% | 0.01% |
| July 8, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 459,572.0000 | 189,565,000 | 3.30% | 0.01% |
| July 8, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $192.97 | 444,889.0000 | 189,565,000 | 3.19% | 0.01% |
| June 30, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 300 | $0.00 | 14,586.2210 | 316,200,000 | 2.10% | 0.00% |
| June 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 14683 | $84.98 | 459,572.0000 | 188,901,000 | 3.30% | 0.01% |
| June 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 14683 | $0.00 | 73,415.0000 | 188,901,000 | 16.67% | 0.01% |
| June 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $211.66 | 444,889.0000 | 188,901,000 | 3.19% | 0.01% |
| May 10, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Restricted Stock Units | 1069 | $0.00 | 10,831.9280 | 316,200,000 | 10.95% | 0.00% |
| May 10, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 617 | $0.00 | 14,286.6270 | 316,200,000 | 4.51% | 0.00% |
| May 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | S | ResMed Common Stock | 14683 | $216.50 | 444,842.0000 | 188,901,000 | 3.20% | 0.01% |
| May 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 13507 | $0.00 | 88,098.0000 | 188,901,000 | 13.29% | 0.01% |
| May 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 13507 | $84.98 | 459,525.0000 | 188,901,000 | 3.03% | 0.01% |
| May 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock Options | 1176 | $0.00 | 101,605.0000 | 188,901,000 | 1.14% | 0.00% |
| May 7, 2024 | RESMED INC | $RMD | Farrell Michael J. | Chief Executive Officer | M | ResMed Common Stock | 1176 | $84.98 | 446,018.0000 | 188,901,000 | 0.26% | 0.00% |
| March 31, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 245 | $0.00 | 13,643.2900 | 316,200,000 | 1.83% | 0.00% |
| Dec. 31, 2023 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Farrell Michael J. | Director | A | Phantom Stock Units | 267 | $0.00 | 13,373.4520 | 313,800,000 | 2.04% | 0.00% |